(Total Views: 248)
Posted On: 03/17/2020 9:26:16 PM
Post# of 36567
I agree. My only issue and it’s been a huge one has been the lack of PRs that have some backbone to them.
A company that puts out PRs that don’t provide any information on the products, what’s going on with the company, funding, etc.. is of concern.
When timelines keep getting unmet is also a concern.
I would love to see a big pharma take an interest in Generex / NGIO, but with the continued lack of met timelines, lack of information, I’m concerned with that reality anytime soon.
I’m hoping the 10Q shows us something positive. I’m hoping for anything positive at this point. We have months until NGIO might get listed OR not.
Fingers crossed.
A company that puts out PRs that don’t provide any information on the products, what’s going on with the company, funding, etc.. is of concern.
When timelines keep getting unmet is also a concern.
I would love to see a big pharma take an interest in Generex / NGIO, but with the continued lack of met timelines, lack of information, I’m concerned with that reality anytime soon.
I’m hoping the 10Q shows us something positive. I’m hoping for anything positive at this point. We have months until NGIO might get listed OR not.
Fingers crossed.
(1)
(0)
